{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T06:35:54Z","timestamp":1648708554664},"reference-count":30,"publisher":"Baishideng Publishing Group Inc.","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2006]]},"DOI":"10.3748\/wjg.v12.i31.5017","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T03:37:10Z","timestamp":1458099430000},"page":"5017","source":"Crossref","is-referenced-by-count":1,"title":["Effects of chronic therapy with non-steroideal antinflammatory drugs on gastric permeability of sucrose: A study on 71 patients with rheumatoid arthritis"],"prefix":"10.3748","volume":"12","author":[{"given":"Marta","family":"Maino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Retail & Provider Perspective, National Prescription Audit, 1999-2000 Plymouth, PA: IMS Health; 2000;."},{"key":"ref2","unstructured":"Editoriale: Il mercato farmaceutico mondiale nel 2001. Bollettino Informazione sui farmaci 2001;6:275-277."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199506060-00001"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021633"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021735"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.8.1609"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.9561"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Laine L. Nonsteroidal anti-inflammatory drug gastropathy. Gastrointest Endosc Clin N Am 1996;6:489-504.","DOI":"10.1016\/S1052-5157(18)30351-9"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199906173402407"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Pounder R. Silent peptic ulceration: deadly silence or golden silence. Gastroenterology 1989;96:626-631.","DOI":"10.1016\/S0016-5085(89)80058-7"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05905.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Meddings JB, Sutherland LR, Byles NI, Wallace JL. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 1993;104:1619-1626.","DOI":"10.1016\/0016-5085(93)90637-R"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00300.x"},{"key":"ref14","unstructured":"Altavilla N, Moussa AM, Seghini P. Sucrose test and serum pepsinogens as markers of inflammation and damage in Helicobacter pylori related gastritis. Gut 2002;51:A1-A120."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36013"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.21907"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-4-199508150-00001"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.10.1247"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011233432103"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ph.57.030195.003025"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000171168"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018807412030"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(01)80157-2"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Graham DY, Smith JL, Spjut HJ, Torres E. Gastric adaptation. Studies in humans during continuous aspirin administration. Gastroenterology 1988;95:327-333.","DOI":"10.1016\/0016-5085(88)90487-8"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Schmassmann A. Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs. Am J Med 1998;104:43S-51S; discussion 79S-80S.","DOI":"10.1016\/S0002-9343(97)00211-8"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01454.x"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803123381105"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(00)80821-X"},{"key":"ref29","unstructured":"Regula J, Deckers CPM, Raps D. Comparison of 20 mg and 40 mg Pantoprazole vs 20 mg Omeprazole in the prevention of the development of gastrointestinal lesions in rheumatic patients with continuous NSAID intake. Gut 2001;49:1229."},{"key":"ref30","unstructured":"Dietrich K, Buchner M, Carro GP. Pantoprazole 20 mg s.i.d. is superior to Misoprostol 200 aeg b.i.d. in the prevention of gastrointestinal lesions in rheumatic patients with continuous NSAID intake. Gut 2001;49:1491."}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T11:47:50Z","timestamp":1567684070000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v12\/i31\/5017.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":30,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v12.i31.5017","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}